FIELD: medicine. SUBSTANCE: method involves determining immunomodulation activity of a preparation in different phases of biological rhythm and differentiating specific against non-specific components of immunomodulation action. t Immunomodulation activity is determined from contraction phenomenon. EFFECT: high accuracy in evaluating and selecting immunomodulator agents. 10 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| GEL FOR WOUND TREATMENT | 1999 |
|
RU2169553C1 |
| OINTMENT FOR PYODERMIA TREATMENT | 1999 |
|
RU2169554C1 |
| METHOD FOR EVALUATING PROTECTIVE PROPERTIES OF IMMUNOMODULATING PREPARATIONS | 2003 |
|
RU2268468C2 |
| METHOD OF PREPARING VACCINE BCG-M FOR SPARING PRIMARY IMMUNIZATION | 2000 |
|
RU2170588C1 |
| METHOD OF PREPARING VACCINE BCG "IMURON" FOR BLADDER CANCER IMMUNOTHERAPY | 1999 |
|
RU2170103C1 |
| METHOD FOR DETECTING CYTOPROLIFERATIVE FACTOR IN AGING MAMMALIAN AND HUMAN BODIES IN THEIR LIFETIME | 2001 |
|
RU2204135C2 |
| METHOD OF STREPTOCOCCUS HYALURONIDASE PREPARING | 2000 |
|
RU2174557C1 |
| METHOD OF DIFFERENTIATION OF LISTERIA MONOCYTOGENES CULTURE | 2001 |
|
RU2196827C1 |
| METHOD OF PREPARING PURIFIED LIQUID STAPHYLOCOCCUS ANATOXIN FOR SPECIFIC IMMUNOTHERAPY OF PATIENTS WITH STAPHYLOCOCCUS INFECTION | 2000 |
|
RU2169580C1 |
| METHOD OF BLOCKING CHRONIC INTEGRATION INFECTION CAUSED BY HUMAN IMMUNODEFICIENCY VIRUS | 2008 |
|
RU2370536C1 |
